{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:49:42Z","timestamp":1791344982091,"version":"4.3.1"},"reference-count":187,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.healun.2012.06.002","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T20:11:56Z","timestamp":1344456716000},"page":"913-933","source":"Crossref","is-referenced-by-count":204,"title":["World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult\u2014a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation"],"prefix":"10.1016","volume":"31","author":[{"given":"James C.","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"DeMarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Givertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Borlaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Eduardo","family":"Rame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mardi","family":"Gomberg-Maitland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Murali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"McGlothlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn M.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond L.","family":"Benza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2012.06.002_bib1","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib2","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/0002-9149(90)90555-F","article-title":"Relation of mean pulmonary arterial wedge pressure and left ventricular end-diastolic pressure","volume":"66","author":"Flores","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00145608","article-title":"Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review","volume":"34","author":"Kovacs","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2012.06.002_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ccm.2006.12.001","article-title":"Pulmonary hypertension associated with left-sided heart disease","volume":"28","author":"Oudiz","year":"2007","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.healun.2012.06.002_bib5","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00059-005-2696-3","article-title":"Pulmonary hypertension in advanced heart failure","volume":"30","author":"Ghio","year":"2005","journal-title":"Herz"},{"key":"10.1016\/j.healun.2012.06.002_bib7","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0735-1097(99)00408-8","article-title":"Pulmonary hypertension and exercise intolerance in patients with heart failure","volume":"34","author":"Butler","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ahj.2009.02.022","article-title":"Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database","volume":"157","author":"Khush","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2012.06.002_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","article-title":"Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure","volume":"37","author":"Ghio","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib10","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1161\/CIRCULATIONAHA.108.838698","article-title":"Age-associated increases in pulmonary artery systolic pressure in the general population","volume":"119","author":"Lam","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","author":"Borlaug","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/CIRCHEARTFAILURE.110.959437","article-title":"Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes","volume":"4","author":"Lewis","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.111.051540","article-title":"Pulmonary capillary wedge pressure augments right ventricular pulsatile loading","volume":"125","author":"Tedford","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib14","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.102.14.1718","article-title":"Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management","volume":"102","author":"Moraes","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib15","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.107.653584","article-title":"Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure","volume":"117","author":"Haddad","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib16","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/CIRCULATIONAHA.107.653576","article-title":"Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle","volume":"117","author":"Haddad","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jacc.2004.02.033","article-title":"Pathologic assessment of vasculopathies in pulmonary hypertension","volume":"43","author":"Pietra","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/978-1-60761-500-2_29","article-title":"PPARgamma and the pathobiology of pulmonary arterial hypertension","volume":"661","author":"Rabinovitch","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.healun.2012.06.002_bib19","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/01.RES.69.4.1088","article-title":"Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure","volume":"69","author":"Ontkean","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2012.06.002_bib20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0002-9149(98)00400-7","article-title":"The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure","volume":"82","author":"Cooper","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jacc.2009.05.021","article-title":"Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil","volume":"54","author":"Melenovsky","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF03256644","article-title":"Prostanoids for pulmonary arterial hypertension","volume":"2","author":"Galie","year":"2003","journal-title":"Am J Respir Med"},{"key":"10.1016\/j.healun.2012.06.002_bib23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0002-9149(98)00439-1","article-title":"Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure","volume":"82","author":"Montalescot","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","article-title":"A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)","volume":"134","author":"Califf","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2012.06.002_bib25","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1164\/rccm.200611-1615OC","article-title":"How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension","volume":"175","author":"Kerbaul","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2012.06.002_bib26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.CIR.85.2.504","article-title":"Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure","volume":"85","author":"Cody","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib27","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0735-1097(94)90387-5","article-title":"Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure","volume":"23","author":"Tsutamoto","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib28","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1161\/01.CIR.101.25.2922","article-title":"Acute endothlin A receptor blockade cause selective pulmonary vasodilation in patients with chronic heart failure","volume":"101","author":"Givertz","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib29","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1161\/01.CIR.0000034444.31846.F4","article-title":"Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan","volume":"106","author":"Ooi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0008-6363(97)00097-7","article-title":"Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion","volume":"35","author":"Sun","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.healun.2012.06.002_bib31","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/CIRCULATIONAHA.108.847707","article-title":"Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/316947","article-title":"BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension","volume":"68","author":"Machado","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.healun.2012.06.002_bib33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/CIRCULATIONAHA.106.655266","article-title":"Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility","volume":"116","author":"Nagendran","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib34","first-page":"942","article-title":"Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy","volume":"13","author":"Fawzy","year":"2004","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.healun.2012.06.002_bib35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM196509022731001","article-title":"Effects of Mitral-Valve Replacement on the pulmonary vascular dynamics of patients with pulmonary hypertension","volume":"273","author":"Braunwald","year":"1965","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2012.06.002_bib36","doi-asserted-by":"crossref","first-page":"I107","DOI":"10.1161\/01.CIR.33.4S1.I-107","article-title":"Reversibility of pulmonary hypertension following cardiac surgery","volume":"33","author":"Reeve","year":"1966","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.CIR.19.3.386","article-title":"The role of vessel tone in maintaining pulmonary vascular resistance in patients with mitral stenosis","volume":"19","author":"Semler","year":"1959","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0735-1097(89)90180-0","article-title":"Isolated chronic mitral regurgitation with preserved systolic left ventricular function and severe pulmonary hypertension","volume":"14","author":"Alexopoulos","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib39","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1161\/01.CIR.102.19.2378","article-title":"Impact of atrioventricular compliance on pulmonary artery pressure in mitral stenosis: an exercise echocardiographic study","volume":"102","author":"Schwammenthal","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib40","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.echo.2007.08.024","article-title":"Hemodynamic and prognostic implications of net atrioventricular compliance in patients with mitral stenosis","volume":"21","author":"Kim","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.healun.2012.06.002_bib41","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/eurheartj\/ehq294","article-title":"Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: A Multicenter Long-term International Study","volume":"32","author":"Barbieri","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2012.06.002_bib42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1010-7940(98)00042-6","article-title":"High-risk mitral valve replacement in severe pulmonary hypertension\u201430 years experience","volume":"13","author":"Cesnjevar","year":"1998","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2012.06.002_bib43","first-page":"7","article-title":"Pulmonary hypertension in mitral valve surgery","volume":"21","author":"Cevese","year":"1980","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.healun.2012.06.002_bib44","doi-asserted-by":"crossref","first-page":"II137","DOI":"10.1161\/01.CIR.92.9.137","article-title":"Long-term outcome of cardiac surgery in patients with mitral stenosis and severe pulmonary hypertension","volume":"92","author":"Vincens","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/hrt.37.1.74","article-title":"Extreme pulmonary hypertension caused by mitral valve disease","volume":"37","author":"Ward","year":"1975","journal-title":"Br Heart J"},{"key":"10.1016\/j.healun.2012.06.002_bib46","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jtcvs.2009.03.046","article-title":"Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: a propensity score-based comparison between an early surgical strategy and a conservative treatment approach","volume":"138","author":"Montant","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2012.06.002_bib47","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2006.05.021","volume":"48","author":"Bonow","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1053\/j.jvca.2009.01.011","article-title":"Evaluation and comparison of early hemodynamic changes after elective mitral valve replacement in patients with severe and mild pulmonary arterial hypertension","volume":"23","author":"Tempe","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2012.06.002_bib49","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-5223(19)38358-8","article-title":"The early course of pulmonary artery hypertension in patients undergoing mitral valve replacement with cardioplegic arrest","volume":"88","author":"Foltz","year":"1984","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2012.06.002_bib50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/thx.31.3.332","article-title":"Mitral valve replacement in the presence of severe pulmonary hypertension","volume":"31","author":"Kaul","year":"1976","journal-title":"Thorax"},{"key":"10.1016\/j.healun.2012.06.002_bib51","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.RES.0000181432.73920.b1","article-title":"Reduced wall compliance suppresses Akt-dependent apoptosis protection stimulated by pulse perfusion","volume":"97","author":"Li","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2012.06.002_bib52","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jacc.2007.11.082","article-title":"Restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis","volume":"51","author":"Magne","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0735-1097(92)90050-W","article-title":"Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group","volume":"19","author":"Costard-Jackle","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib54","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/CIRCHEARTFAILURE.110.960864","article-title":"The relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure","volume":"4","author":"Aronson","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib55","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-116-11-888","article-title":"Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy","volume":"116","author":"Abramson","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2012.06.002_bib56","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1161\/01.CIR.0000013771.30198.82","article-title":"Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk","volume":"105","author":"Cappola","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib57","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-8703(85)90461-2","article-title":"Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure","volume":"110","author":"Franciosa","year":"1985","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2012.06.002_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/CIRCHEARTFAILURE.108.785501","article-title":"Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone","volume":"1","author":"Lewis","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib59","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1161\/CIRCULATIONAHA.107.686576","article-title":"Development of a ventilatory classification system in patients with heart failure","volume":"115","author":"Arena","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0735-1097(96)00436-6","article-title":"Determinants of pulmonary hypertension in left ventricular dysfunction","volume":"29","author":"Enriquez-Sarano","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib61","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/eurheartj\/ehl561","article-title":"Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure","volume":"28","author":"Tumminello","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2012.06.002_bib62","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0735-1097(94)00511-N","article-title":"Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure","volume":"25","author":"Di Salvo","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib63","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/CIRCHEARTFAILURE.109.900134","article-title":"Right ventricular response to intensive medical therapy in advanced decompensated heart failure","volume":"3","author":"Verhaert","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib64","first-page":"526","article-title":"Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation","volume":"9","author":"Erickson","year":"1990","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.healun.2012.06.002_bib65","first-page":"331","article-title":"Pulmonary vascular resistance and the risk of heart transplantation","volume":"7","author":"Kirklin","year":"1988","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.healun.2012.06.002_bib66","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0735-1097(94)90859-1","article-title":"Hemodynamic effects of inhaled nitric oxide in heart failure","volume":"24","author":"Semigran","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib67","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2006.06.008","article-title":"Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates\u20142006","volume":"25","author":"Mehra","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.06.002_bib68","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2006.11.052","article-title":"Prognostic importance of pulmonary hypertension in patients with heart failure","volume":"99","author":"Kjaergaard","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib69","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jacc.2003.11.040","article-title":"Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry","volume":"43","author":"Klapholz","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib70","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.amjcard.2010.02.039","article-title":"Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction","volume":"106","author":"Leung","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib71","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2012.06.002_bib72","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1378\/chest.06-1571","article-title":"Unexplained pulmonary hypertension in elderly patients","volume":"131","author":"Shapiro","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.healun.2012.06.002_bib73","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.amjcard.2008.01.054","article-title":"Usefulness of the pulmonary arterial systolic pressure to predict pulmonary arterial wedge pressure in patients with normal left ventricular systolic function","volume":"101","author":"Bouchard","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib74","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCHEARTFAILURE.111.962209","article-title":"Discerning pulmonary venous from pulmonary arterial hypertension without the help of a catheter","volume":"4","author":"Borlaug","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib75","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCHEARTFAILURE.110.958801","article-title":"Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction","volume":"4","author":"Thenappan","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib76","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0735-1097(90)90174-N","article-title":"Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure","volume":"15","author":"Gibbs","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib77","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jacc.2007.10.061","article-title":"Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study","volume":"51","author":"Bourge","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib78","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1378\/chest.93.3_Supplement.97S","article-title":"Increased wedge pressure facilitates decreased lung vascular resistance during upright exercise","volume":"93","author":"Reeves","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.healun.2012.06.002_bib79","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/CIRCULATIONAHA.108.787101","article-title":"Exercise-induced pulmonary arterial hypertension","volume":"118","author":"Tolle","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCULATIONAHA.106.626226","article-title":"Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure","volume":"115","author":"Lewis","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib81","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cardfail.2008.02.012","article-title":"Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest","volume":"14","author":"Ennezat","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib82","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.jacc.2009.04.008","article-title":"Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension","volume":"54","author":"Hoeper","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1378\/chest.08-2008","article-title":"Association of the metabolic syndrome with pulmonary venous hypertension","volume":"136","author":"Robbins","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.healun.2012.06.002_bib84","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.CIR.102.8.865","article-title":"Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension","volume":"102","author":"Nagaya","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib85","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/hrt.2007.139295","article-title":"Determinants of exercise-induced pulmonary hypertension in patients with normal left ventricular ejection fraction","volume":"95","author":"Ha","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.healun.2012.06.002_bib86","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0735-1097(85)80477-0","article-title":"Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients","volume":"6","author":"Currie","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib87","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1164\/rccm.200811-1691OC","article-title":"Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension","volume":"179","author":"Fisher","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2012.06.002_bib88","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0735-1097(86)80300-X","article-title":"Doppler echocardiographic assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertension","volume":"8","author":"Louie","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib89","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1053\/je.1999.v12.a99069","article-title":"Echocardiographic features of primary pulmonary hypertension","volume":"12","author":"Bossone","year":"1999","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.healun.2012.06.002_bib90","doi-asserted-by":"crossref","first-page":"H1528","DOI":"10.1152\/ajpheart.01031.2005","article-title":"Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension","volume":"290","author":"Gan","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.healun.2012.06.002_bib91","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.echo.2007.10.003","article-title":"Noninvasive differentiation of pulmonary arterial and venous hypertension using conventional and Doppler tissue imaging echocardiography","volume":"21","author":"Willens","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.healun.2012.06.002_bib92","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib93","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2012.06.002_bib94","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0735-1097(02)02973-X","article-title":"A simple method for noninvasive estimation of pulmonary vascular resistance","volume":"41","author":"Abbas","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib95","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1540-8175.2008.00837.x","article-title":"Noninvasive estimation of pulmonary vascular resistance in pulmonary hypertension","volume":"26","author":"Rajagopalan","year":"2009","journal-title":"Echocardiography"},{"key":"10.1016\/j.healun.2012.06.002_bib96","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1164\/rccm.201004-0601OC","article-title":"Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension","volume":"183","author":"Arkles","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2012.06.002_bib97","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jcmg.2009.12.011","article-title":"Heart failure with normal ejection fraction: the complementary roles of echocardiography and CMR imaging","volume":"3","author":"Leong","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2012.06.002_bib98","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/eurheartj\/ehr173","article-title":"Non-invasive estimation of pulmonary vascular resistance with cardiac magnetic resonance","volume":"32","author":"Garcia-Alvarez","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2012.06.002_bib99","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2008.08.033","article-title":"Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension","volume":"52","author":"Benza","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib100","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1161\/CIRCULATIONAHA.104.531368","article-title":"Cardiovascular interventional magnetic resonance imaging","volume":"112","author":"Lederman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib101","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1161\/01.CIR.0000143138.02493.DD","article-title":"Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension","volume":"110","author":"Kuehne","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib102","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib103","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0002-9149(97)00216-6","article-title":"Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging","volume":"79","author":"Pons-Llado","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib104","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2214\/AJR.07.3997","article-title":"MRI of cardiomyopathy","volume":"191","author":"Belloni","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.healun.2012.06.002_bib105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1532-429X-10-36","article-title":"Routine evaluation of left ventricular diastolic function by cardiovascular magnetic resonance: a practical approach","volume":"10","author":"Rathi","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.healun.2012.06.002_bib106","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/01.CIR.56.6.924","article-title":"Occult constrictive pericardial disease","volume":"56","author":"Bush","year":"1977","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib107","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1378\/chest.93.6.1144","article-title":"The effects of rapid volume expansion on the right and left cardiac filling pressures after coronary artery bypass surgery","volume":"93","author":"Pacold","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.healun.2012.06.002_bib108","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurjhf\/hfp171","article-title":"Caveat medicus! Pulmonary hypertension in the elderly: a word of caution","volume":"12","author":"Boilson","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib109","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1161\/01.CIR.90.6.2780","article-title":"Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction","volume":"90","author":"Loh","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib110","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/01.CIR.92.4.819","article-title":"Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction","volume":"92","author":"Louie","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib111","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0735-1097(90)90196-V","article-title":"Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure","volume":"15","author":"Stevenson","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib112","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0002-9149(89)90320-2","article-title":"Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation","volume":"63","author":"Stevenson","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib113","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1388-9842(03)00059-X","article-title":"Reversible pulmonary hypertension in heart transplant candidates\u2014pretransplant evaluation and outcome after orthotopic heart transplantation","volume":"5","author":"Klotz","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib114","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ejcts.2004.01.052","article-title":"Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study","volume":"25","author":"Martin","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2012.06.002_bib115","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0735-1097(02)02002-8","article-title":"Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications","volume":"40","author":"Malouf","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib116","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/01.CIR.76.4.819","article-title":"Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation","volume":"76","author":"Bhatia","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib117","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/euhj.1998.1155","article-title":"High and low pulmonary vascular resistance in heart transplant candidates","volume":"20","author":"Lindelow","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2012.06.002_bib118","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0002-9149(94)90496-0","article-title":"Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure","volume":"74","author":"Bocchi","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib119","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1164\/ajrccm.157.5.9708065","article-title":"Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis","volume":"157","author":"Humbert","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2012.06.002_bib120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1378\/chest.113.1.237","article-title":"Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease","volume":"113","author":"Palmer","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.healun.2012.06.002_bib121","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1378\/chest.121.2.656","article-title":"Pulmonary edema caused by inhaled nitric oxide therapy in two patients with pulmonary hypertension associated with the CREST syndrome","volume":"121","author":"Preston","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.healun.2012.06.002_bib122","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1067\/mhj.2003.146","article-title":"Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension","volume":"145","author":"Gavazzi","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2012.06.002_bib123","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","article-title":"Sodium nitroprusside for advanced low-output heart failure","volume":"52","author":"Mullens","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib124","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/0002-8703(91)90580-B","article-title":"Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents","volume":"122","author":"Murali","year":"1991","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2012.06.002_bib125","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/01.CIR.83.6.2038","article-title":"Inhaled nitric oxide","volume":"83","author":"Frostell","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib126","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.CIR.93.2.266","article-title":"Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans","volume":"93","author":"Cooper","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib127","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1161\/01.CIR.0000134595.80170.62","article-title":"Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential","volume":"109","author":"Ichinose","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib128","first-page":"366","article-title":"Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance","volume":"13","author":"Kieler-Jensen","year":"1994","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.06.002_bib129","doi-asserted-by":"crossref","first-page":"I76","DOI":"10.1161\/01.cir.0000032875.55215.cb","article-title":"Inhaled Nitric Oxide as a Preoperative Test (INOP Test I): the INOP Test Study Group","volume":"106","author":"Balzer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib130","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S1010-7940(02)00488-8","article-title":"Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance","volume":"22","author":"Sablotzki","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2012.06.002_bib131","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(95)92681-X","article-title":"Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide","volume":"346","author":"Miller","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2012.06.002_bib132","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cardfail.2005.01.009","article-title":"Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension","volume":"11","author":"Michaels","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib133","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/ajhp\/62.6.606","article-title":"Nesiritide for secondary pulmonary hypertension in patients with end-stage heart failure","volume":"62","author":"O'Dell","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.healun.2012.06.002_bib134","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","article-title":"Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure","volume":"111","author":"Sackner-Bernstein","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O'Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2012.06.002_bib136","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1053-2498(98)00064-3","article-title":"Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine","volume":"18","author":"Stanek","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.06.002_bib137","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.healun.2012.06.002_bib138","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.CIR.97.8.744","article-title":"Endothelin receptors in the failing and nonfailing human heart","volume":"97","author":"Ponicke","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib139","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/01.CIR.99.16.2118","article-title":"Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure","volume":"99","author":"Zolk","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib140","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0008-6363(00)00101-2","article-title":"Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts","volume":"47","author":"Yamamoto","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.healun.2012.06.002_bib141","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00004872-200204000-00035","article-title":"Prevention of diastolic heart failure by endothelin type A receptor antagonist through inhibition of ventricular structural remodeling in hypertensive heart","volume":"20","author":"Yamamoto","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.healun.2012.06.002_bib142","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0735-1097(00)00649-5","article-title":"Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure","volume":"35","author":"Spieker","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib143","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(04)16723-8","article-title":"Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin A Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Anand","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2012.06.002_bib144","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1388-9842(01)00210-0","article-title":"Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology\u2014WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME","volume":"3","author":"Coletta","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib145","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0735-1097(02)02708-0","article-title":"RITZ-5: randomized intravenous TeZosentan (an endothelin-A\/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study","volume":"41","author":"Kaluski","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib146","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1388-9842(01)00149-0","article-title":"Clinical trials update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure","volume":"3","author":"Louis","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib147","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0735-1097(03)00194-3","article-title":"Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4)","volume":"41","author":"O'Connor","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib148","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","article-title":"Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials","volume":"298","author":"McMurray","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2012.06.002_bib149","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0167-5273(02)00182-1","article-title":"Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?","volume":"85","author":"Kalra","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardfail.2004.05.006","article-title":"Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study","volume":"11","author":"Packer","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib151","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1399-0012.2005.00475.x","article-title":"Initial experience with bosentan therapy in patients considered ineligible for heart transplantation because of severe pulmonary hypertension","volume":"20","author":"Perez-Villa","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2012.06.002_bib152","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2165\/00003495-198836020-00003","article-title":"Milrinone","volume":"36","author":"Young","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.healun.2012.06.002_bib153","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0735-1097(96)00399-3","article-title":"Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension","volume":"28","author":"Givertz","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib154","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2012.06.002_bib155","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2012.06.002_bib156","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1093\/eurheartj\/ehp338","article-title":"Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials","volume":"30","author":"Metra","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2012.06.002_bib157","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0735-1097(00)00790-7","article-title":"Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure","volume":"36","author":"Katz","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib158","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0002-9149(02)02586-9","article-title":"Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension","volume":"90","author":"Lepore","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib159","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jacc.2006.08.066","article-title":"Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart","volume":"49","author":"Forfia","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib160","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.healun.2012.06.002_bib161","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.amjcard.2004.07.157","article-title":"Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure","volume":"94","author":"Alaeddini","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib162","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.jacc.2007.07.078","article-title":"Long-term use of sildenafil in the therapeutic management of heart failure","volume":"50","author":"Guazzi","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2012.06.002_bib163","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.clpt.2004.06.003","article-title":"Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure","volume":"76","author":"Guazzi","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.healun.2012.06.002_bib164","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1378\/chest.127.5.1647","article-title":"Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide","volume":"127","author":"Lepore","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.healun.2012.06.002_bib165","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.healun.2009.04.013","article-title":"Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and \u22125 inhibition","volume":"28","author":"Botha","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.06.002_bib166","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.healun.2010.02.004","article-title":"Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension","volume":"29","author":"Perez-Villa","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.06.002_bib167","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.transproceed.2007.08.077","article-title":"Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure","volume":"39","author":"Maruszewski","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2012.06.002_bib168","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.transproceed.2007.08.069","article-title":"Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates","volume":"39","author":"Zakliczynski","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2012.06.002_bib169","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.healun.2003.09.024","article-title":"Sildenafil for pulmonary hypertension after heart transplantation","volume":"23","author":"Kulkarni","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.06.002_bib170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCHEARTFAILURE.108.796789","article-title":"PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support","volume":"1","author":"Tedford","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2012.06.002_bib171","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCULATIONAHA.107.716373","article-title":"Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension","volume":"116","author":"Lewis","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib172","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib173","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1177\/0091270008319793","article-title":"Single-dose pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase stimulator BAY 63\u20132521: an ascending-dose study in healthy male volunteers","volume":"48","author":"Frey","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.healun.2012.06.002_bib174","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1183\/09031936.00039808","article-title":"First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension","volume":"33","author":"Grimminger","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2012.06.002_bib175","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1183\/09031936.00182909","article-title":"Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study","volume":"36","author":"Ghofrani","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2012.06.002_bib176","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/01.mat.0000169125.21268.d7","article-title":"Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension","volume":"51","author":"Haddad","year":"2005","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2012.06.002_bib177","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0041-1345(00)00820-4","article-title":"Is partially reversible pulmonary hypertension a contraindication for heart transplantation?","volume":"32","author":"Baldovinos","year":"2000","journal-title":"Transplantation proceedings"},{"key":"10.1016\/j.healun.2012.06.002_bib178","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00002480-199707000-00019","article-title":"Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency","volume":"43","author":"Adamson","year":"1997","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2012.06.002_bib179","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0003-4975(02)04372-2","article-title":"Mechanical ventricular support lowers pulmonary vascular resistance in a patient with congential heart disease","volume":"75","author":"Petrofski","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2012.06.002_bib180","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1525-1594.2004.47332.x","article-title":"Left ventricular unloading in a patient with end-stage cardiomyopathy and medically unresponsive pulmonary hypertension","volume":"28","author":"Al-Khaldi","year":"2004","journal-title":"Artif Organs"},{"key":"10.1016\/j.healun.2012.06.002_bib181","doi-asserted-by":"crossref","first-page":"M733","DOI":"10.1097\/00002480-199609000-00085","article-title":"Pulmonary hypertension is not a risk factor for RVAD use and death after left ventricular assist system support","volume":"42","author":"Smedira","year":"1996","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2012.06.002_bib182","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejcts.2004.11.001","article-title":"Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates","volume":"27","author":"Salzberg","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2012.06.002_bib183","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejcts.2006.12.036","article-title":"Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices","volume":"31","author":"Zimpfer","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2012.06.002_bib184","doi-asserted-by":"crossref","first-page":"I8","DOI":"10.1161\/CIRCULATIONAHA.106.677898","article-title":"Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices","volume":"116","author":"Haft","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2012.06.002_bib185","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.athoracsur.2008.05.016","article-title":"Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices","volume":"86","author":"Patel","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2012.06.002_bib186","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.healun.2009.05.030","article-title":"Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support","volume":"29","author":"Torre-Amione","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.06.002_bib187","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.athoracsur.2006.08.051","article-title":"Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices","volume":"83","author":"Klodell","year":"2007","journal-title":"Ann Thorac Surg"}],"updated-by":[{"DOI":"10.1016\/j.healun.2012.12.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000}}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249812011242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249812011242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T06:54:35Z","timestamp":1687676075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249812011242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":187,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1053249812011242"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2012.06.002","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}